| abstract |
The present disclosure relates to novel compounds of formula (I) as defined in this specification, and compositions comprising such novel compounds. Such compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by hepatitis C virus (HCV). Accordingly, the present disclosure also pertains to a method of treating HCV-associated diseases or conditions using such novel compounds or compositions comprising such novel compounds. |